HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives
The UK's MHRA has approved the Rx-to-OTC switch of two identical progestogen-only contraceptive pills from HRA Pharma and Maxwellia. Hana and Lovima (both 75mcg desogestrel) will be launched at the end of the month.
You may also be interested in...
Perrigo is targeting Germany for its next Rx-to-OTC switch of a daily contraceptive (desogestrel 75μg) after seeing success in the US and UK with Opill and Hana respectively.
UK consumers will soon be able to purchase at an "accessible" price branded levonorgestrel-based emergency contraceptive, LoviOne, marketed by switch specialists Maxwellia.
Making better use of Rx-to-OTC switch and existing OTC drugs could generate an additional £3.1bn a year in cost savings for the UK's National Health System, PAGB argues in a new report.